Welcure Drugs & Pharmaceuticals Ltd Board of Directors
Board of Directors at Welcure Drugs & Pharmaceuticals Ltd
Gagan Juneja
Non-Exec. & Independent Dir.
Manowar Ali
Company Sec. & Compli. Officer
Mohd. Alam
Independent Director
Pradeep Terse
Additional Director
Rajeev Mehra
Additional Director
Key Highlights
- Chintan Didawala joins the board as Executive Director & MD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Yogeshkumar Prajapati joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Bhumika Pradhan joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ravi Thakor joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Palak Jain joins the board as Company Sec. & Compli. Officer, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Welcure Drugs & Pharmaceuticals Ltd
NSE: WELCUREDRUGS
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 30 Mar 2026 | 0.24 |
| 27 Mar 2026 | 0.25 |
| 25 Mar 2026 | 0.26 |
| 24 Mar 2026 | 0.25 |
| 23 Mar 2026 | 0.24 |
| 20 Mar 2026 | 0.25 |
| 19 Mar 2026 | 0.25 |
| 18 Mar 2026 | 0.26 |
| 17 Mar 2026 | 0.27 |
| 16 Mar 2026 | 0.27 |
Company Fundamentals for Welcure Drugs & Pharmaceuticals Ltd
Market Cap
29 Cr
EPS
0.3
P/E Ratio (TTM)
0.8
P/B Ratio (TTM)
0.2
Day’s High
0.25
Day’s Low
0.24
DTE
0.9
ROE
25.6
52 Week High
1.44
52 Week Low
0.24
ROCE
17.5
Market Price of Welcure Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Welcure Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Welcure Drugs & Pharmaceuticals Ltd News Hub
Welcure Drugs & Pharmaceuticals reports standalone net loss of Rs 0.35 crore in the June 2024 quarter
Net Loss of Welcure Drugs & Pharmaceuticals reported to Rs 0.35 crore in the quarter ended June 2024
Read more
14 Aug 24
Welcure Drugs & Pharmaceuticals to table results
Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 A
Read more
09 Aug 24
Welcure Drugs & Pharmaceuticals to hold board meeting
Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 Se
Read more
30 Aug 24
Welcure Drugs & Pharmaceuticals to conduct AGM
Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will
Read more
11 Sept 24
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Welcure Drugs & Pharmaceuticals Ltd
How are members of Welcure Drugs & Pharmaceuticals Ltd Board of Directors selected?
Members of the Welcure Drugs & Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Welcure Drugs & Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Welcure Drugs & Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Welcure Drugs & Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Welcure Drugs & Pharmaceuticals Ltd Board of Directors meet?
The Welcure Drugs & Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Welcure Drugs & Pharmaceuticals Ltd Board of Directors?
The Welcure Drugs & Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Welcure Drugs & Pharmaceuticals Ltd?
The current Board of Directors at Welcure Drugs & Pharmaceuticals Ltd includes Chintan Didawala( Executive Director & MD) ,Yogeshkumar Prajapati( Independent Non Exe. Director) ,Bhumika Pradhan( Independent Non Exe. Director) ,Ravi Thakor( Independent Non Exe. Director) ,Palak Jain( Company Sec. & Compli. Officer) . The full list can be found on Welcure Drugs & Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
